311 related articles for article (PubMed ID: 9615264)
1. Prevention of gastroduodenal damage with omeprazole in patients receiving continuous NSAIDs treatment. A double blind placebo controlled study.
Bianchi Porro G; Lazzaroni M; Petrillo M; Manzionna G; Montrone F; Caruso I
Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):43-7. PubMed ID: 9615264
[TBL] [Abstract][Full Text] [Related]
2. Multicenter clinical trial of zinc acexamate in the prevention of nonsteroidal antiinflammatory drug induced gastroenteropathy. Spanish Study Group on NSAID Induced Gastroenteropathy Prevention.
Rodríguez de la Serna A; Díaz-Rubio M
J Rheumatol; 1994 May; 21(5):927-33. PubMed ID: 8064736
[TBL] [Abstract][Full Text] [Related]
3. Double-blind, double-dummy endoscopic comparison of the mucosal protective effects of misoprostol versus ranitidine on naproxen-induced mucosal injury to the stomach and duodenum in rheumatic patients.
Bianchi Porro G; Lazzaroni M; Petrillo M
Am J Gastroenterol; 1997 Apr; 92(4):663-7. PubMed ID: 9128319
[TBL] [Abstract][Full Text] [Related]
4. A multicenter, randomized, double-blind, active-comparator, placebo-controlled, parallel-group comparison of the incidence of endoscopic gastric and duodenal ulcer rates with valdecoxib or naproxen in healthy subjects aged 65 to 75 years.
Goldstein JL; Aisenberg J; Lanza F; Schwartz H; Sands GH; Berger MF; Pan S
Clin Ther; 2006 Mar; 28(3):340-51. PubMed ID: 16750449
[TBL] [Abstract][Full Text] [Related]
5. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
Goldstein JL; Huang B; Amer F; Christopoulos NG
Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480
[TBL] [Abstract][Full Text] [Related]
6. Prevention with sucralfate gel of NSAID-induced gastroduodenal damage in arthritic patients.
Miglioli M; Bianchi Porro G; Vaira D; Menegatti M; Brunetti G; Petrillo M; Ardizzone S; Frizziero L; Montrone F; Grandinetti G
Am J Gastroenterol; 1996 Nov; 91(11):2367-71. PubMed ID: 8931419
[TBL] [Abstract][Full Text] [Related]
7. Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment: double-blind, randomized, placebo-controlled trial.
de Leest HT; Steen KS; Lems WF; Bijlsma JW; van de Laar MA; Huisman AM; Vonkeman HE; Houben HH; Kadir SW; Kostense PJ; van Tulder MW; Kuipers EJ; Boers M; Dijkmans BA
Helicobacter; 2007 Oct; 12(5):477-85. PubMed ID: 17760715
[TBL] [Abstract][Full Text] [Related]
8. Helicobacter pylori eradication in the healing and recurrence of benign gastric ulcer: a two-year, double-blind, placebo controlled study.
Lazzaroni M; Perego M; Bargiggia S; Maconi G; Fiocca R; Solcia E; Franceschi M; Cesana B; Bianchi Porro G
Ital J Gastroenterol Hepatol; 1997 Jun; 29(3):220-7. PubMed ID: 9646213
[TBL] [Abstract][Full Text] [Related]
9. Effect of Helicobacter pylori eradication on anti-thrombotic dose aspirin-induced gastroduodenal mucosal injury.
Giral A; Ozdogan O; Celikel CA; Tozun N; Ulusoy NB; Kalayci C
J Gastroenterol Hepatol; 2004 Jul; 19(7):773-7. PubMed ID: 15209624
[TBL] [Abstract][Full Text] [Related]
10. Clinical and gastroscopic evaluation of amtolmetin guacyl versus diclofenac in patients with rheumatoid arthritis.
Bianchi Porro G; Montrone F; Lazzaroni M; Manzionna G; Caruso I
Ital J Gastroenterol Hepatol; 1999; 31(5):378-85. PubMed ID: 10470596
[TBL] [Abstract][Full Text] [Related]
11. Primary prevention of diclofenac associated ulcers and dyspepsia by omeprazole or triple therapy in Helicobacter pylori positive patients: a randomised, double blind, placebo controlled, clinical trial.
Labenz J; Blum AL; Bolten WW; Dragosics B; Rösch W; Stolte M; Koelz HR
Gut; 2002 Sep; 51(3):329-35. PubMed ID: 12171952
[TBL] [Abstract][Full Text] [Related]
12. [Sulglicotide in the prevention of gastric disease induced by NSAID. Double-blind controlled study versus placebo].
Magarò M; Altomonte L; Zoli A; Mirone L; Wielmarin A; Massari M; Destito G; Nazzari M; Psilogenis M
Minerva Dietol Gastroenterol; 1989; 35(1):27-30. PubMed ID: 2725926
[TBL] [Abstract][Full Text] [Related]
13. An endoscopic comparison of gastroduodenal injury with over-the-counter doses of ketoprofen and acetaminophen.
Lanza FL; Codispoti JR; Nelson EB
Am J Gastroenterol; 1998 Jul; 93(7):1051-4. PubMed ID: 9672328
[TBL] [Abstract][Full Text] [Related]
14. Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non-steroidal anti-inflammatory drug therapy. A Nordic multicentre study.
Ekström P; Carling L; Wetterhus S; Wingren PE; Anker-Hansen O; Lundegårdh G; Thorhallsson E; Unge P
Scand J Gastroenterol; 1996 Aug; 31(8):753-8. PubMed ID: 8858742
[TBL] [Abstract][Full Text] [Related]
15. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK
Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of esomeprazole (20 mg once daily) for reducing the risk of gastroduodenal ulcers associated with continuous use of low-dose aspirin.
Yeomans N; Lanas A; Labenz J; van Zanten SV; van Rensburg C; Rácz I; Tchernev K; Karamanolis D; Roda E; Hawkey C; Nauclér E; Svedberg LE
Am J Gastroenterol; 2008 Oct; 103(10):2465-73. PubMed ID: 18637091
[TBL] [Abstract][Full Text] [Related]
17. [Ranitidine in the treatment of non-steroidal anti-inflammatory agent-induced damage of the stomach and duodenal mucosa. Results of a randomized, placebo-controlled double-blind study in patients with rheumatic diseases].
Simon B; Beckers KH; Biewer W; Bouzo MH; Dammann HG; Gebest HJ; Müller P; Schütz E
Z Gastroenterol; 1988 Jun; 26(6):310-3. PubMed ID: 3061183
[TBL] [Abstract][Full Text] [Related]
18. Nizatidine prevents peptic ulceration in high-risk patients taking nonsteroidal anti-inflammatory drugs.
Levine LR; Cloud ML; Enas NH
Arch Intern Med; 1993 Nov; 153(21):2449-54. PubMed ID: 8215749
[TBL] [Abstract][Full Text] [Related]
19. Gastroduodenal mucosa and dyspeptic symptoms in arthritic patients during chronic nonsteroidal anti-inflammatory drug use.
Larkai EN; Smith JL; Lidsky MD; Graham DY
Am J Gastroenterol; 1987 Nov; 82(11):1153-8. PubMed ID: 3499815
[TBL] [Abstract][Full Text] [Related]
20. Effect of H. pylori status on gastric ulcer healing in patients continuing nonsteroidal anti-inflammatory therapy and receiving treatment with lansoprazole or ranitidine.
Campbell DR; Haber MM; Sheldon E; Collis C; Lukasik N; Huang B; Goldstein JL
Am J Gastroenterol; 2002 Sep; 97(9):2208-14. PubMed ID: 12358234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
